Urinary 5-HIAA for Diagnosis of Acute Appendicitis in Children, Does it Help?
BUILDING UP A DIAGNOSTIC MODEL OF ACUTE APPENDICITIS IN CHILDREN USING URINARY 5-HYDROXY INDOL ACETIC ACID
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
1.1- Study design: Patients were randomly categorized into two groups A and B. Randomization was achieved using closed envelop method.
Group A (n= 95) included patients that were evaluated using our institutional protocol. This protocol consists of assessment of children using PAS, ultrasound of abdomen and pelvis and serum levels of C-reactive protein.
Group B (n= 96) included children that were evaluated by our institutional protocol. In addition, all children gave a mid- stream urine sample for spot urinary 5-HIAA detection. Detailed history was taken. This mainly was to exclude cases with history of foods or drugs that may affect level of serotonin in urine such as mono amino oxidase inhibitors.
All related clinical data and laboratory investigations were recorded. 1.2- Quantitation of urinary 5-HIAA level: From each participant, a random urine sample was obtained to assess the urinary 5-HIAA level using a solid phase competitive enzyme-linked immunosorbent assay (ELISA) technique. The commercial kit was purchased and provided by LDN, DN Labor Diagnosika Nord GmbH & Co. Nordhorn, Germany; Catalog #: BA E-1900. As stated by the manufacturer, the urine samples were methylated to derivatize the 5-HIAA. On the provided microtitre plate, the methylated standards, controls and samples are added. 5-HIAA antiserum was then added and incubated for 1 hour. After equilibration, excess free antigen and antigen-antibody complexes are washed out. The affixed bounded antibodies to the solid phase were detected by an anti-rabbit IgG-peroxidase conjugate using TMB as a substrate. The reaction is measured on a microplate reader (Tecan Spectra II, Switzerland), at 450 nm. Quantification of unknown sample concentration is processed by drawing a standard curve with known standard concentrations. The results of 5-HIAA were divided by urinary creatinine and expressed as mg/g creatinine. The inter-assay and intra-assay coefficient of variation were 10.8% and 8.6% respectively.
1.3- Clinical outcome: Diagnosis of acute appendicitis was confirmed by histopathological examination of resected appendix. According to operative findings and pathological reports, the condition ranged from negative appendix to different types of acute appendicitis (catarrhal, suppurative, perforated or gangrenous).
Children did not full filling the requirements for diagnosis as acute appendicitis were discharged on symptomatic treatment or after referral to pediatric emergency department.
Readmitted cases were recorded. 1.4- Statistical analysis: Statistical analysis was done using IBM SPSS V. 24 (IBM, NY, USA). A descriptive analysis was obtained for patients included in the study. Shapiro-Wilk test was conducted to check for normal distribution of dependent variables, such as urinary 5-HIAA, CRP and histopathological findings. X2 test was used to compare the categorical data. Student T-test was used to compare the normally distributed variable between two groups. Mann-Whitney U test and Kruskal-Wallis test were used for comparing the non-normally distributed variables of two and more than two groups, respectively. Binary logistic regression was performed to determine the independent predictors for acute appendicitis and to combine 5-HIAA and PAS results in both groups. Pearson correlation was used for correlating the urinary 5-HIAA with other acute appendicitis predictors. Receiver operating characteristic (ROC) curve was constructed to assess the diagnostic efficacy of acute appendicitis predictors. The optimal cutoff value for each predictor was assessed via the Youden index. The value of AUC ranged from 0.5 to 1.0. The ability of a diagnostic test to identify patients with appendicitis was considered optimal as AUC value reached closer to 1.0. P-value <0.05 was considered significant
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gharbeya
-
Tanta, Gharbeya, Egypt, 31111
- Tanta University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- all children with suspected acute appendicitis
Exclusion Criteria:
- children received drugs that may affect normal values of urinary 5-HIAA as mono mono oxidase inhibitors
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: group A
subjected to institutional protocol of diagnosis of acute appendicitis
|
urinary assessment of 5-HIAA
|
|
Active Comparator: group B
subjected to institutional protocol of diagnosis of acute appendicitis plus measurement of urinary 5-HIAA
|
urinary assessment of 5-HIAA
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
accurate diagnosis of acute appendicitis in children
Time Frame: 1 day
|
number of cases that have been diagnosed as having acute appendicitis
|
1 day
|
|
decreasing incidence of negative appendectomy
Time Frame: 1 day
|
number of cases that are not appendicitis and not operated
|
1 day
|
|
decreasing number of readmitted cases with diagnosis of acute appendicitis
Time Frame: 3 days
|
number of cases that had been readmitted with diagnosis of acute appendicitis in both groups
|
3 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Mohammad G Mohammad, Tanta University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 33944/7/20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diagnosis of Acute Appendicitis in Children
-
NCT02178423CompletedUltrasound for Diagnosis of CVC Position in Children
-
NCT07016919RecruitingUncomplicated Acute Appendicitis in Children
-
NCT06762275RecruitingAppendicitis Acute | Acute Abdomen in Children
-
NCT05391269CompletedAppendicitis | Acute Appendicitis | Pathology | Appendicitis (Diagnosis)
-
NCT06344598RecruitingImproving the Early Diagnosis of Osteoporosis in Adults and Children Living in the Abay Region of Kazakhstan
-
NCT07370896CompletedAcute Appendicitis | Appendicitis (Diagnosis)
-
NCT07275268Not yet recruiting
-
NCT07563933Not yet recruitingPost Operative Antibiotic Therapy of Acute Appendicitis
-
NCT04806789CompletedChildren, Only | Acute Appendicitis
-
NCT04033198UnknownAcute Appendicitis in Elderly
Clinical Trials on measurement of urinary 5-HIAA
-
NCT07578038Not yet recruiting
-
NCT05813730Recruiting
-
NCT07264504RecruitingFormaldehyde | Pathological Anatomy and Cytology
-
NCT06236698CompletedHypertension | Primary Aldosteronism
-
NCT03958279Terminated
-
NCT01196663Unknownto Evaluate the Performance of the TMS Thermometer and | Improve Its Algorithm
-
NCT06445426CompletedCystometry Using a Novel Microsensor System in Patients With Neurogenic Bladder Dysfunction (PEPRE2)Spinal Cord Injuries | Urinary Bladder, Neurogenic
-
NCT04010708CompletedIodine Deficiency | Iodine Status in Pregnancy
-
NCT06371781CompletedExcessive Weight Gain During Pregnancy
-
NCT02897401UnknownSmoking | Carcinogenesis of the Nicotine